RNS Number:2102J
Advanced Medical Solutions Grp PLC
26 March 2003





DEALINGS BY DIRECTORS



DISCLOSURE OF INTERESTS IN SHARES OR DEBENTURES AND NOTIFICATIONS OF DEALINGS
UNDER THE STOCK EXCHANGE REQUIREMENTS



1. Name of Company:



Advanced Medical Solutions Group plc



2. Name of Director:



Donald Evans



3. Please state whether notification indicates that it is in respect of holding
of the Director named in 2 above or holding of that person's spouse or children
under the age of 18 or in respect of a non-beneficial interest:



In respect of holding of that person's spouse



4. Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them.  (If notified):



Pamela Evans



5. Please state whether notification relates to a person(s) connected with the
Director named in 2 above and identify the connected person(s):



Pamela Evans



6. Please state the nature of the transaction and the nature and extent of the
director's interest in the transaction:



Acquisition of shares



7. Number of shares/amount of stock acquired:



50,000 ordinary shares



8. Percentage of issued class:



0.035%



9. Number of shares/amount of stock disposed:



-



10. Percentage of issued class:



-



11. Class of security:



Ordinary shares of 5p each



12. Price per share:



7.75p



13. Date of transaction:



25 March 2003



14. Date company informed:



25 March 2003



15. Total holding following this notification:



517,680 ordinary shares



16. Total percentage holding of issued class following this notification:



0.364%

____________________________________________________________________



IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THE
FOLLOWING BOXES.



17. Date of grant:



-



18. Period during which or date on which exercisable:



-



19. Total amount paid (if any) for grant of the option:



-



20. Description of shares or debentures involved: class, number:



-



21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise:



-



22. Total number of shares or debentures over which options held following this
notification:



-

____________________________________________________________________



23. Any additional information:







24. Name of contact and telephone number for queries:



Mary Tavener, Finance Director, 01606 863500





25. Name and signature of authorised company official responsible for making
this notification:




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSUNAKROWROURR